Altimmune (ALT) Current Assets (2010 - 2026)
Altimmune (ALT) recorded Current Assets of $334.82 million in Q2 2026, up 77.7% from $188.42 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Altimmune (ALT) Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Altimmune reported Current Assets of $278.19 million, up 102.7% from FY2024.
- Annual Current Assets has a five-year compound annual growth rate of 3.9% (FY2020 to FY2025).
- Across earlier years, Current Assets came in at $137.25 million in FY2024 (-34.5%), $209.63 million in FY2023 (+8.7%), $192.81 million in FY2022 (-5.5%) and $204.13 million in FY2021 (-11.3%).
- The Q2 2026 figure is the highest quarterly Current Assets in data going back to Q4 2010.
- On a year-over-year basis, Current Assets has increased for five consecutive quarters, with growth averaging 37.3% over the last eight quarters.
- Peak year-over-year performance for Current Assets in the last five years was growth of 115.6% in Q1 2026, against a decline of 34.5% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $334.68 million (Q1 2026), $278.19 million (Q4 2025) and $216.62 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Altimmune | 411.69 Mn | -730.54 Mn | - | 334.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 334.82 Mn |
| Mar 31, 2026 | 334.68 Mn |
| Dec 31, 2025 | 278.19 Mn |
| Sep 30, 2025 | 216.62 Mn |
| Jun 30, 2025 | 188.42 Mn |
| Mar 31, 2025 | 155.26 Mn |
| Dec 31, 2024 | 137.25 Mn |
| Sep 30, 2024 | 145.76 Mn |
| Jun 30, 2024 | 171.19 Mn |
| Mar 31, 2024 | 187.52 Mn |
| Dec 31, 2023 | 209.63 Mn |
| Sep 30, 2023 | 152.96 Mn |
| Jun 30, 2023 | 169.53 Mn |
| Mar 31, 2023 | 173.11 Mn |
| Dec 31, 2022 | 192.81 Mn |
| Sep 30, 2022 | 211.00 Mn |
| Jun 30, 2022 | 195.50 Mn |
| Mar 31, 2022 | 191.09 Mn |
| Dec 31, 2021 | 204.13 Mn |
| Sep 30, 2021 | 218.26 Mn |
API Access
Altimmune Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();